NAYA Biosciences Inc. (NAYA): Market Valuation

Graphic logo of NAYA Bio (NAYA)

The NAYA Biosciences (NAYA) stock chart demonstrates a market capitalization of 0.00. The business relies on AI-driven automation for antibody development and the operation of state-of-the-art sterile laboratories equipped with calibrated instrumentation. However, the lack of profitability and the early stage of testing create significant threats, including potential additional share offerings and equity dilution for holders due to the high risks of clinical failures.

nayabiosciences.com - NAYA Market Capitalization (period 07/04/2022 - 04/28/2025)
Product sample of NAYA Biosciences

Market capitalization represents the aggregate value of all a company's shares, reflecting the market valuation of its equity. This metric is calculated by multiplying the current asset price by the total number of outstanding securities. By analyzing the market capitalization trends of a company, an investor determines the business's fundamental margin of safety during periods of low volatility. For NAYA Biosciences (NAYA), this indicator confirms its status as a defensive asset, driven by the autonomy of its product cycle and stable demand for unique medical developments.

Competitors of NAYA Biosciences (NAYA)

Market Capitalization ONC (BeiGene)|Market Capitalization Halozyme Therapeutics, Inc. HALO|RVMD: Market Valuation|Market Value Ascentage Pharma Corp|CGON: Market Capitalization|urogen.com (URGN) - Market Capitalization|BCAX (Bicara Therapeutics) - Market Capitalization|Market Valuation Personalis Inc (PSNL)|Market Capitalization ERAS|Market Capitalization Delcath Corp (DCTH)|Market Value Y-mAbs Therapeutics YMAB|AURA: Market Capitalization|Candel - Market Capitalization|Accuray Inc (ARAY) - Market Valuation|SLS: Market Capitalization|Market Value Actuate Therapeutics Inc (ACTU)|Market Value Citius Oncology, Inc.|HURA: Market Value|Market Valuation TARA (Protara Therapeutics, Inc.)|FATE (Fate Therapeutics Inc) - Market Value|Market Capitalization WHWK (Aadi Bioscience)|TCRX - Market Valuation|CSBR: Market Valuation|XBIT - Market Capitalization|cel-sci.com (CVM) - Market Value|OS Therapies Inc. - Market Value|RADX (Radiopharm Theranostics) - Market Capitalization|Market Value Artiva ARTV|Market Value Adlai Nortye Ltd. (ANL)|verupharma.com - Market Capitalization|Market Capitalization TPST (Tempest Therapeutics, Inc.)|Market Capitalization Xilio Therapeutics Inc XLO|RENB: Market Valuation|Market Value Mural Oncology plc|KAPA: Market Capitalization|OnKure Therapeutics (OKUR) - Market Capitalization|Market Valuation GDTC|CRIS: Market Value|Market Capitalization APLM|Market Value THAR (Tharimmune Corporation)|Market Capitalization ADVB (Advanced Biomed)|Market Capitalization genprex.com (GNPX)|CLDI - Market Value|Market Value sunshinebiopharma.com|xeneticbio.com (XBIO) - Market Value|SLRX - Market Capitalization|PPBT (Purple Biotech) - Market Capitalization|Market Valuation AON (AONC)|Market Capitalization BGNE|Market Capitalization Checkpoint Therapeutics Inc.|Market Capitalization ELEV (Elevation Oncology)|iCAD Inc. (ICAD) - Market Value|IKNA - Market Value|NTBL (notablelabs.com) - Market Capitalization|VIRX: Market Capitalization|Market Valuation MorphoSys Inc|AAPGV (Ascentage Pharma Group Ltd) - Market Capitalization